Biogen Inc. (BIIB) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 06:43 ET. Consensus EPS estimate is $2.04.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | FY2026 Q2 | $2.94 | $3.60 | +22.4% | $2.74B |
| 2026-04-29 | FY2026 Q1 | $3.05 | $3.57 | +17.0% | $2.48B |
| 2026-02-06 | FY2025 Q4 | $1.63 | $1.99 | +22.1% | $2.28B |
| 2025-10-30 | FY2025 Q3 | $3.88 | $4.81 | +24.0% | $2.45B |
| 2025-07-31 | FY2025 Q2 | $3.90 | $5.47 | +40.3% | $2.65B |
| 2025-05-01 | FY2025 Q1 | $2.90 | $3.02 | +4.1% | $2.43B |
| 2025-02-12 | FY2024 Q4 | $3.43 | $3.44 | +0.3% | $2.45B |
| 2024-10-30 | FY2024 Q3 | $3.77 | $4.08 | +8.2% | $2.47B |
BIIB has beaten consensus EPS in 8 of its last 8 reported quarters.
See BIIB on the live calendar →